KLK4 and COVID-19: In hospitalized patients with COVID-19, a significant increase in the levels of intact and cleaved kininogen in blood plasma, as well as kallikrein:C1 esterase inhibitor (C1INH) and FXIIa:C1INH complexes were found, as evidence of the kallikrein–kinin system’s activation [90].